Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Non-Current Liabilities (2020 - 2025)

Agilon Health's Other Non-Current Liabilities history spans 6 years, with the latest figure at $52.3 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 31.27% year-over-year to $52.3 million; the TTM value through Dec 2025 reached $52.3 million, down 31.27%, while the annual FY2025 figure was $52.3 million, 31.27% down from the prior year.
  • Other Non-Current Liabilities reached $52.3 million in Q4 2025 per AGL's latest filing, up from $50.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $91.1 million in Q2 2022 to a low of $2.1 million in Q3 2022.
  • Average Other Non-Current Liabilities over 5 years is $46.9 million, with a median of $56.4 million recorded in 2025.
  • Peak YoY movement for Other Non-Current Liabilities: crashed 90.38% in 2021, then skyrocketed 3185.25% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $8.7 million in 2021, then skyrocketed by 851.79% to $82.5 million in 2022, then decreased by 14.68% to $70.4 million in 2023, then grew by 8.16% to $76.1 million in 2024, then plummeted by 31.27% to $52.3 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Other Non-Current Liabilities are $52.3 million (Q4 2025), $50.3 million (Q3 2025), and $54.9 million (Q2 2025).